Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa
- 1 September 1992
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (9) , 1847-1851
- https://doi.org/10.1128/aac.36.9.1847
Abstract
Multiple-drug-resistant mutants were isolated from Pseudomonas aeruginosa PAO1 on agar plates containing ofloxacin and cefsulodin. These mutants were four to eight times more resistant to meropenem, cephems, carbenicillin, quinolones, tetracycline, and chloramphenicol than the parent strain was. In contrast, these mutants showed no significant changes in their susceptibilities to all carbapenems except meropenem. In these mutants, the amounts of an outer membrane protein with an apparent molecular weight of 49,000 (designated OprM) were increased compared with the amount in PAO1. Multiple-drug-resistant mutants of this type were also isolated from PAO1 on agar plates containing meropenem. Approximately 5% of clinical isolates showed cross-resistance to meropenem, cephems, and quinolones, concomitant with overproduction of OprM. Moreover, these two phenotypes, i.e., multiple-drug resistance and overproduction of OprM, were cotransferable by transduction. These data suggest that overproduction of OprM is associated with cross-resistance to meropenem, cephems, and quinolones in P. aeruginosa. The ofloxacin-cefsulodin-resistant mutant required higher concentrations of meropenem to induce beta-lactamase than PAO1 did, indicating the possibility that this mutation involves decreased outer membrane permeability to meropenem.Keywords
This publication has 18 references indexed in Scilit:
- Increased resistance to multiple drugs by introduction of the Enterobacter cloacae romA gene into OmpF porin-deficient mutants of Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1991
- Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacinAntimicrobial Agents and Chemotherapy, 1990
- New norfloxacin resistance gene in Pseudomonas aeruginosa PAOAntimicrobial Agents and Chemotherapy, 1990
- Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1990
- Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditisAntimicrobial Agents and Chemotherapy, 1989
- In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1989
- Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane proteinAntimicrobial Agents and Chemotherapy, 1987
- Mutations producing resistance to norfloxacin in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1987
- Emergence of Resistance to Imipenem During Therapy for Pseudomonas aeruginosa InfectionsThe Journal of Infectious Diseases, 1986
- Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genesAntimicrobial Agents and Chemotherapy, 1982